Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Computer-Aided Molecular Design
|
September 3, 2017
Blinded evaluation of farnesoid X receptor (FXR) ligands binding using molecular docking and free energy calculations
Edithe Selwa, Eddy Elisée, Agustin Zavala, et al.
ACS Infectious Diseases
|
February 22, 2019
Genetic, Biochemical, and Structural Characterization of CMY-136 β-Lactamase, a Peculiar CMY-2 Variant
Agustin Zavala, Pascal Retailleau, Eddy Elisée, et al.
ACS Infectious Diseases
|
March 12, 2020
Substrate Specificity of OXA-48 after β5-β6 Loop Replacement
Laura Dabos, Agustin Zavala, Rémy A Bonnin, et al.
ACS Synthetic Biology
|
September 27, 2017
A Modular Receptor Platform To Expand the Sensing Repertoire of Bacteria
Hung-Ju Chang, Pauline Mayonove, Agustin Zavala, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
July 20, 2017
Beta-lactamase database (BLDB) - structure and function
Thierry Naas, Saoussen Oueslati, Rémy A Bonnin, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase
Laura Dabos, Pierre Bogaerts, Remy A Bonnin, et al.
The Journal of Antimicrobial Chemotherapy
|
May 26, 2019
Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity
Saoussen Oueslati, Bogdan I Iorga, Linda Tlili, et al.
Nature Communications
|
March 19, 2024
Cryo-EM structures of type IV pili complexed with nanobodies reveal immune escape mechanisms
David Fernandez-Martinez, Youxin Kong, Sylvie Goussard, et al.
Antimicrobial Agents and Chemotherapy
|
January 17, 2023
Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant
Laura Dabos, Joanna E Raczynska, Pierre Bogaerts, et al.
European Journal of Medicinal Chemistry
|
April 16, 2021
Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)
Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Computer-Aided Molecular Design
|
September 3, 2017
Blinded evaluation of farnesoid X receptor (FXR) ligands binding using molecular docking and free energy calculations
Edithe Selwa, Eddy Elisée, Agustin Zavala, et al.
ACS Infectious Diseases
|
February 22, 2019
Genetic, Biochemical, and Structural Characterization of CMY-136 β-Lactamase, a Peculiar CMY-2 Variant
Agustin Zavala, Pascal Retailleau, Eddy Elisée, et al.
ACS Infectious Diseases
|
March 12, 2020
Substrate Specificity of OXA-48 after β5-β6 Loop Replacement
Laura Dabos, Agustin Zavala, Rémy A Bonnin, et al.
ACS Synthetic Biology
|
September 27, 2017
A Modular Receptor Platform To Expand the Sensing Repertoire of Bacteria
Hung-Ju Chang, Pauline Mayonove, Agustin Zavala, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
July 20, 2017
Beta-lactamase database (BLDB) - structure and function
Thierry Naas, Saoussen Oueslati, Rémy A Bonnin, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase
Laura Dabos, Pierre Bogaerts, Remy A Bonnin, et al.
The Journal of Antimicrobial Chemotherapy
|
May 26, 2019
Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity
Saoussen Oueslati, Bogdan I Iorga, Linda Tlili, et al.
Nature Communications
|
March 19, 2024
Cryo-EM structures of type IV pili complexed with nanobodies reveal immune escape mechanisms
David Fernandez-Martinez, Youxin Kong, Sylvie Goussard, et al.
Antimicrobial Agents and Chemotherapy
|
January 17, 2023
Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant
Laura Dabos, Joanna E Raczynska, Pierre Bogaerts, et al.
European Journal of Medicinal Chemistry
|
April 16, 2021
Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)
Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun, et al.
Page
of 1